Subscribe to Updates
Get breaking Canadian news, immigration updates, and money tips delivered straight to your inbox. Join The Maple Briefing — free, every Thursday.
Browsing: pharmaceuticals
The Apotex profit guidance raise follows a $100.8 million second quarter profit, with Canadian revenue up about 14% on new product launches.
Health Canada has approved IMCIVREE (setmelanotide) for weight management in patients as young as 4 with acquired hypothalamic obesity — the first targeted therapy approved in Canada for the rare condition.
CSL Canada says the first patients are now receiving ANDEMBRY, the first once-monthly treatment targeting factor XIIa for hereditary angioedema prevention — with public coverage expanding in Quebec, Alberta, and through federal programs.






